These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23122819)

  • 21. Non-classical azoreductase secretion in Clostridium perfringens in response to sulfonated azo dye exposure.
    Morrison JM; John GH
    Anaerobe; 2015 Aug; 34():34-43. PubMed ID: 25881497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A budesonide prodrug accelerates treatment of colitis in rats.
    Cui N; Friend DR; Fedorak RN
    Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiome-Wide Search for Bacterial Azoreductases Reveals Potentially Uncharacterized Azoreductases Encoded in the Human Gut Microbiome.
    Braccia DJ; Minabou Ndjite G; Weiss A; Levy S; Abeysinghe S; Jiang X; Pop M; Hall B
    Drug Metab Dispos; 2023 Jan; 51(1):142-153. PubMed ID: 36116790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450-based cancer gene therapy: recent advances and future prospects.
    Waxman DJ; Chen L; Hecht JE; Jounaidi Y
    Drug Metab Rev; 1999 May; 31(2):503-22. PubMed ID: 10335450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Carceller E; Salas J; Merlos M; Giral M; Ferrando R; Escamilla I; Ramis J; García-Rafanell J; Forn J
    J Med Chem; 2001 Aug; 44(18):3001-13. PubMed ID: 11520209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
    Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
    Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents.
    Sharma R; Rawal RK; Gaba T; Singla N; Malhotra M; Matharoo S; Bhardwaj TR
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5332-8. PubMed ID: 23968824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the mitigating effect of colon-specific bioreversible codrugs of mycophenolic acid and aminosugars in an experimental colitis model in Wistar rats.
    Chopade SS; Dhaneshwar SS
    World J Gastroenterol; 2018 Mar; 24(10):1093-1106. PubMed ID: 29563754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease.
    Carrette O; Favier C; Mizon C; Neut C; Cortot A; Colombel JF; Mizon J
    Dig Dis Sci; 1995 Dec; 40(12):2641-6. PubMed ID: 8536525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches and opportunities in colon-specific drug delivery.
    Rubinstein A
    Crit Rev Ther Drug Carrier Syst; 1995; 12(2-3):101-49. PubMed ID: 9501968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice.
    Gareb B; Dijkstra G; Kosterink JGW; Frijlink HW
    Int J Pharm; 2019 Jan; 554():366-375. PubMed ID: 30414898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone.
    Doh MJ; Jung YJ; Kim Ih; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):258-63. PubMed ID: 12735681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole.
    Kim H; Lee Y; Yoo H; Kim J; Kong H; Yoon JH; Jung Y; Kim YM
    J Drug Target; 2012 Apr; 20(3):255-63. PubMed ID: 22118327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic switching of sulpiride, an anti-psychotic and prokinetic drug, to an anti-colitic drug using colon-specific drug delivery.
    Kim D; Kim W; Jeong S; Kim D; Yoo JW; Jung Y
    Drug Deliv Transl Res; 2019 Feb; 9(1):334-343. PubMed ID: 30426357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
    Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
    Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.